NCT01195558
- Conditions
- Blindness, Eye Diseases, Nervous System Diseases, +6 more
- Locations
-
- Vanda Pharmaceuticals Washington D.C., District of Columbia, United States
Clinical trial condition
Explore clinical trials studying Sleep-wake Disorder in Blind Individuals. Study availability and eligibility vary by location and protocol.
NCT01195558